NUVL (STOCKS)
Nuvalent, Inc. Class A Common Stock
$123.320000
+0.070000 (+0.06%)
Prev close: $123.250000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- James R. Porter
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $9,745.98M
- Employees
- 218
- P/E (TTM)
- -20.36
- P/B (TTM)
- 8.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$10.58M |
| Operating Expenses | $438.90M |
| Research and Development | $316.16M |
| Other Operating Expenses | $122.74M |
| Operating Income/Loss | -$438.90M |
| Income/Loss From Continuing Operations After Tax | -$450.10M |
| Income/Loss From Continuing Operations Before Tax | -$449.48M |
| Income Tax Expense/Benefit | $596.00K |
| Net Income/Loss | -$450.07M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$450.10M |
| Net Income/Loss Available To Common Stockholders, Basic | -$450.10M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$6.06 |
| Diluted Earnings Per Share | -$6.06 |
| Basic Average Shares | 223,477,468 |
| Diluted Average Shares | 223,477,468 |
| Assets | $1.33B |
| Current Assets | $1.31B |
| Noncurrent Assets | $23.21M |
| Liabilities | $156.78M |
| Current Liabilities | $81.05M |
| Accounts Payable | $22.14M |
| Wages | $8.21M |
| Other Current Liabilities | $50.70M |
| Noncurrent Liabilities | $75.73M |
| Equity | $1.17B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.17B |
| Liabilities And Equity | $1.33B |
| Net Cash Flow From Operating Activities | -$312.79M |
| Net Cash Flow From Operating Activities, Continuing | -$312.79M |
| Net Cash Flow From Investing Activities | -$168.91M |
| Net Cash Flow From Investing Activities, Continuing | -$168.91M |
| Net Cash Flow From Financing Activities | $520.59M |
| Net Cash Flow From Financing Activities, Continuing | $520.59M |
| Net Cash Flow | $38.90M |
| Net Cash Flow, Continuing | $38.90M |
| Comprehensive Income/Loss | -$455.23M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$452.28M |
| Other Comprehensive Income/Loss | -$127.57M |